U.S. Markets close in 3 hrs 34 mins

ALR Technologies Inc. (ALRT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0460-0.0016 (-3.42%)
As of 12:01PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0476
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0457 - 0.0470
52 Week Range0.0450 - 0.0750
Avg. Volume95,052
Market Cap24.413M
Beta (5Y Monthly)3.48
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    ALR Technologies and Infinovo Sign Memorandum of Understanding to Manufacture World’s First CGM for Diabetic Pets

    SINGAPORE, Dec. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with Infinovo Medical Co. Ltd for a global supply agreement of their P3 Continuous Glucose Monitor (CGM) for use by ALRT in the animal health sector. Under the terms of the MOU, ALR Technologies and Infinovo will collaborate to integrate Infinovo’s P3 CGM with ALRT’s proprietary GluCurve

  • GlobeNewswire

    ALR Technologies Releases Select Results from Market Research on Diabetic Pet Industry; Market Demand High for Innovation

    GluCurve is the world’s first continuous glucose monitor (CGM) for diabetic dogs and catsGluCurve eliminates need for manual, costly and cumbersome “glucose curves” that are today’s standard of care2017 AVMA Report shows between 28,000-32,000 veterinary practices in U.S.97% of DVM survey respondents indicated they’d use a pet CGM system to diagnose and manage diabetic dogs and cats as soon as available SINGAPORE, Oct. 21, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB

  • GlobeNewswire

    ALR Technologies Releases New Website and Investor Presentation

    SINGAPORE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today announces that the Company has released a new investor presentation that can be viewed at The Company invites investors and interested parties to explore the recently redesigned corporate website. “ALRT is at an inflection point, moving forward with high-level negotiations and due diligence processes that will be transformational to